secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0001437749-24-031268
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharma closes $5.435M second tranche of secured notes; cancels third tranche
--------------------------------------------------------------------------------

- On Oct 10, 2024, closed second tranche: $5.435M principal amount of Senior Secured Convertible Notes (purchase price ~$5.0M) and warrants for 1,846,128 shares.
- Proceeds to repay existing variable priced convertible notes and for general working capital.
- Conversion price is lower of $1.7664 or 92% of lowest 7-day VWAP prior to conversion date.
- Company and investor mutually agreed not to proceed with the third $5.435M tranche.
- Placement agent EF Hutton receives 7% cash fee and up to $50,000 expense reimbursement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000143774924031268/0001437749-24-031268-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000143774924031268/nrxp20241014_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-031268

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer